Anne Wojcicki, co-founder and CEO of 23andMe, explains why she prefers developing internal talent over relying heavily on external senior executive hires.
0:00 / 0:14exact quote · 14.2s
720p mp4 · rendered on demand · StarZero watermark
“Bringing in very senior people, depending on the type of role, it can be really hard culturally because like they come and they want to make a mark for themselves and they want to guide it in a slightly different way. And 23 weeks, it's complicated company. We have research, we have science, we have regulatory.”
quote is from the automated transcript, cleaned for reading:
filler sounds and stutters are removed, nothing is rephrased. names can be misheard
(the analysis reads context, assessments check outside sources). how →
“This is what margin expansion looks like. Like the mistreatment of my grandmother is at the cost of your margin expansion.”
Anne WojcickiJan 24, 2022▶ 4:3620VC: 23andMe's Anne Wojcicki on How To Approach Trust in Business and Personal Relationships, Leadership Lessons from Sheryl Sandberg and Reflections on How The Best Founders Manage Their Boards
AssertionSupported
Wojcicki: 23andMe proved to FDA consumers don't need physician intermediaries
“And what I'm like really proud of with 23 me is that we proved out to the FDA that people are capable of getting their genetic information without having to have a physician or healthcare professional intermediary.”
Anne WojcickiJan 24, 2022▶ 36:3320VC: 23andMe's Anne Wojcicki on How To Approach Trust in Business and Personal Relationships, Leadership Lessons from Sheryl Sandberg and Reflections on How The Best Founders Manage Their Boards
Insight
Wojcicki: Healthcare Sector Incentivizes Managing Sickness Over Promoting Health
“The business of healthcare is not necessarily about you. It's a great area to invest in. There's all kinds of ways you can make money. You know, you can do all kinds of amazing discount cash flows on dialysis and like, think about like, oh, you know, all these…”
Anne WojcickiJan 24, 2022▶ 4:4220VC: 23andMe's Anne Wojcicki on How To Approach Trust in Business and Personal Relationships, Leadership Lessons from Sheryl Sandberg and Reflections on How The Best Founders Manage Their Boards
Opinion
Wojcicki: Early-Stage Private Company Boards Are Not Useful
“Boards at that stage are not Useful and helpful. They get lots of advisors. Like it's not like people sometimes have this misperception of like how valuable a board can be and like how much influence they can have.”
Anne WojcickiJan 24, 2022▶ 22:3920VC: 23andMe's Anne Wojcicki on How To Approach Trust in Business and Personal Relationships, Leadership Lessons from Sheryl Sandberg and Reflections on How The Best Founders Manage Their Boards
Opinion
Wojcicki: The Healthcare System Treats Patients as Incompetent at Self-Care
“Like one, the healthcare world really looks at you as being totally incompetent at taking care of yourself. Like most doctors don't believe you're capable of change.”
Anne WojcickiJan 24, 2022▶ 36:2120VC: 23andMe's Anne Wojcicki on How To Approach Trust in Business and Personal Relationships, Leadership Lessons from Sheryl Sandberg and Reflections on How The Best Founders Manage Their Boards
“If you really want to change healthcare, in some ways you have to give power to the people, like get them to rise up.”
Anne WojcickiJan 24, 2022▶ 5:4920VC: 23andMe's Anne Wojcicki on How To Approach Trust in Business and Personal Relationships, Leadership Lessons from Sheryl Sandberg and Reflections on How The Best Founders Manage Their Boards
Made with StarZero
Turn any episode into a week of clips.
This entire site, over 1,200 episodes transcribed, diarized, checked and made playable,
runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the
moments worth sharing, cuts them, captions them, and reframes them for every feed.
We use essential cookies to make the site work. With your permission we
also use analytics cookies (Google Analytics and Mixpanel) to understand
usage and improve StarZero. See our Cookie Policy.